Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Cancer Cause and Prevention Research

Cancer Cause and Prevention Research (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 112 Aufrufe auf der Seite, davon 26 offen; Aufrufe starten meist im November. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
26
Aufrufe auf der Seite
112

Aufrufe starten meist im November

Über das Programm

Objectives: To identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans. Research programs include: (1) chemical, physical and molecular carcinogenesis;…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)Offen9. Februar 2027
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)Offen25. Mai 2027
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) (Runde 12.2024 – 09.2027)Offen10. September 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) (Runde 11.2024 – 10.2027)Offen8. Oktober 2027
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) (Runde 05.2026 – 10.2027)Offen19. Oktober 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) (Runde 11.2024 – 11.2027)Offen16. November 2027
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2028)Offen7. Januar 2028
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2028)Offen7. Januar 2028
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2028)Offen7. Januar 2028
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) (Runde 09.2024 – 01.2028)Offen7. Januar 2028
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) (Runde 12.2024 – 01.2028)Offen7. Januar 2028
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) (Runde 11.2024 – 01.2028)Offen7. Januar 2028
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) (Runde 09.2024 – 01.2028)Offen7. Januar 2028
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)Offen7. September 2028
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) (Runde 11.2024 – 09.2028)Offen7. September 2028
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)Offen5. Juli 2029
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) (Runde 05.2026 – 07.2029)Offen5. Juli 2029
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)Offen5. November 2029
NIH Research Center Core GrantsGeplant—
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)Geplant—
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)Geplant—
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Geplant—

Frühere Aufrufe

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Cancer Cause and Prevention Research: Wann starten die Förderaufrufe?
Derzeit offen (26): Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (7. Januar 2027), National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer… (7. Januar 2027), Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Opti… (7. Januar 2027), …. Aufrufe starten meist im November.